TY - JOUR
AU - Rudan, Igor
AU - Millington, Tristan
AU - Antal, Karen
AU - Grange, Zoe
AU - Fenton, Lynda
AU - Sullivan, Christopher
AU - Buelo, Audrey
AU - Wood, Rachael
AU - Woolford, Lana
AU - Swann, Olivia
AU - Murray, Josephine-Louise K.
AU - Cullen, L.A.
AU - Moore, Emily
AU - Haider, Fasih
AU - Almaghrabi, Fatima
AU - Jim McMenamin
AU - Agrawal, Utkarsh
AU - Shah, Syed Ahmar
AU - Kerr, Steven
AU - Simpson, Colin R.
AU - Katikireddi, Srinivasa Vittal
AU - Ritchie, Lewis
AU - Robertson, Chris
AU - Sheikh, Aziz
PY - 2022
DA - September
TI - BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland
JO - The Lancet Regional Health - Europe
VL - 23
DO - https://doi.org/10.1016/j.lanepe.2022.100513
AB - BackgroundThe two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against COVID-19 disease in clinical trials of children and young people (CYP). Consequently, we investigated the uptake, safety, effectiveness and waning of the protective effect of the BNT162b2 against symptomatic COVID-19 in CYP aged 12–17 years in Scotland.
PB - Elsevier
UR - https://hdl.handle.net/2164/19244
KW - Coronavirus (COVID-19)
KW - Children, young people and families
KW - Immunisation and screening
ER